Dr. Guillermo Abesada-Terk Jr., MD

  • Spring Hill, FL
  • Medical oncologist
NPI1134313273
Medicare services, 2022
51,789
Part D claims, 2022
205
Publications
7
Clinical trials
7
Industry payments
$20,040
Practice address
501 Se Osceola St, Stuart, FL 34994-2301
Practice phone
Call (772) 223-5952
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Coastal Oncology and Hematology

Physician office · Stuart, Florida

Find Dr. Abesada-Terk's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Guillermo Abesada-Terk Jr. is a medical oncologist in Spring Hill, Florida

Dr. Abesada-Terk practices at Coastal Oncology and Hematology in Stuart, Florida.

Dr. Abesada-Terk's NPI, 1134313273, was assigned on August 31, 2007. Dr. Abesada-Terk graduated from University of Miami, Miller School of Medicine in 1985. Dr. Abesada-Terk holds Florida license ME58862.

NPI and contact details
NPI enumeration date
August 31, 2007
NPI status
Active
Practice phone
(772) 223-5952
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
67
Medical school graduation
1985

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Guillermo Abesada-Terk Jr. practices in Stuart and Spring Hill

Dr. Abesada-Terk's primary practice is Coastal Oncology and Hematology, at 501 Se Osceola St, Stuart, FL 34994-2301. The practice phone is (772) 223-5952. The NPI Registry lists Dr. Abesada-Terk's practice address as 11063 County Line Rd, Spring Hill, FL 34609.

  • Coastal Oncology and HematologyPrimary
    501 Se Osceola St, Stuart, FL 34994-2301Phone(772) 223-5952
  • NPI Registry address
    11063 County Line Rd, Spring Hill, FL 34609 · Hernando CountyPhone(772) 287-4061

Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data

Dr. Guillermo Abesada-Terk Jr. is affiliated with 1 site of care

Dr. Abesada-Terk's primary practice is Coastal Oncology and Hematology in Stuart, Florida.

Coastal Oncology and HematologyPhysician office · Stuart, FloridaPrimary

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Guillermo Abesada-Terk Jr.'s practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abesada-Terk practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Coastal Oncology and HematologyAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Abesada-Terk practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Guillermo Abesada-Terk Jr. is one of 477 medical oncologists in Florida

Medical oncology is Dr. Abesada-Terk's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Abesada-Terk is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Abesada-Terk's licenses on file in 2 states: Florida and Pennsylvania.

Specialties and state licenses

  • Medical oncology, FloridaPrimaryLicense ME58862 · 1990 to 2027 · taxonomy 207RX0202X
  • Pennsylvania license1988 to 1992

Medical oncologists near Dr. Abesada-Terk

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Guillermo Abesada-Terk Jr. billed Medicare for 51,789 services in 2022

CMS data shows 51,789 Medicare services from Dr. Abesada-Terk across 42 procedure codes in 2022. Medicare paid $534,546 for them.

Medicare services, 202251,789
Paid by Medicare$534,546
Procedure codes42

Dr. Abesada-Terk's Medicare services by type, 2021 to 2022

  • 2021
  • 2022
Other services
2021: 41,0102022: 28,62030%
Drugs given in the office
2021: 40,7122022: 17,61457%
Lab and pathology
2021: 4,6202022: 2,76640%
Tests and treatments
2021: 2,1742022: 1,21944%
Surgery
2021: 1,3982022: 88737%
Office and hospital visits
2021: 1,5192022: 68355%

Where Dr. Abesada-Terk's Medicare services took place, 2022

  • In an office51,770100%
  • In a facility190%

Dr. Abesada-Terk compared with the Florida median for medical oncologists, 2022

  • Dr. Abesada-Terk
  • Florida median
Medicare services
51,789vs 19,7552.6 times
Part D claims
205vs 59866% below

Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Abesada-Terk's most billed Medicare procedure codes, 2022

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Abesada-Terk

Need commercial claims for Dr. Abesada-Terk?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Abesada-Terk and other medical oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Guillermo Abesada-Terk Jr.'s patients have a median age of 68

Across all payers, Dmand AI patient panel data puts Dr. Abesada-Terk's median patient age at 68, with 52% women.

Dr. Abesada-Terk's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women52%
  • Men46%

Source: Dmand AI Patient Panel Data

Dr. Guillermo Abesada-Terk Jr. wrote 205 Medicare Part D claims in 2022

In 2022, Dr. Abesada-Terk wrote 205 Medicare Part D claims. They cover 10 drugs, with $723,761 in total drug cost. In 2021, CMS named 395 claims across 18 drugs.

Part D claims, 2022205
Drugs named by CMS10
Total drug cost$723,761

Dr. Abesada-Terk's most prescribed drugs by claims, 2022

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2021 to 2022

  • 2021
  • 2022
Claims for drugs CMS names
2021: 3952022: 20548%

Drugs named by CMS: 10 in 2022, 18 in 2021.

See all prescribing by Dr. Abesada-Terk

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Abesada-Terk by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Guillermo Abesada-Terk Jr. has 7 publications on record

Dmand AI links 7 papers to Dr. Abesada-Terk, published from 2010 to 2014. 2014 was the busiest year, with 2. The most frequent topics are Colorectal Neoplasms, Florida and Medical Oncology. Dr. Abesada-Terk has published most often in J Oncol Pract. Dr. Abesada-Terk's most frequent co-authors are Carlos A. Alemany, MD, Thomas Howard Cartwright, MD and Douglas E. Faig, MD.

Papers7
Years published2010 to 2014

Dr. Abesada-Terk's papers by year, 2010 to 2014

Topics Dr. Abesada-Terk writes about most

  • Colorectal Neoplasms
  • Florida
  • Medical Oncology
  • Quality Indicators, Health Care
  • Quality Assurance, Health Care
  • Breast Neoplasms
  • Guideline Adherence
  • Carcinoma, Non-Small-Cell Lung

Dr. Abesada-Terk's most frequent co-authors

Recent publications by Dr. Abesada-Terk

See all 7 publications and co-authors

See who Dr. Abesada-Terk researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Abesada-Terk works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Guillermo Abesada-Terk Jr. has worked on 7 clinical trials

Dmand AI links Dr. Abesada-Terk to 7 clinical trials, 5 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Adenocarcinoma Of Esophagus, Leukemia, Myeloid, Chronic-Phase and Lymphoma, Large B-Cell, Diffuse. Altor BioScience sponsors the most, 2.

Clinical trials with Dr. Abesada-Terk by phase

  1. NonePhase 1: no trials
  2. 2Phase 1/2: 2 trials
  3. NonePhase 2: no trials
  4. 5Phase 3: 5 trials
  5. NonePhase 4: no trials

Conditions in Dr. Abesada-Terk's trials

  • Adenocarcinoma Of Esophagus
  • Leukemia, Myeloid, Chronic-Phase
  • Lymphoma, Large B-Cell, Diffuse
  • Melanoma
  • Non-Muscle Invasive Bladder Neoplasms

Investigators on the most trials with Dr. Abesada-Terk

Recent clinical trials with Dr. Abesada-Terk

See all 7 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Guillermo Abesada-Terk Jr. received $20,040 in industry payments from 2016 to 2024

CMS Open Payments shows 1,177 general payments to Dr. Abesada-Terk from 67 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,072.

General payments to Dr. Abesada-Terk by program year, 2016 to 2024

General payments to Dr. Abesada-Terk by kind, 2016 to 2024

$20Kin total
  • Food and beverage$18,88294%
  • Education$1,1576%

Companies that paid Dr. Abesada-Terk the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Abesada-Terk

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Guillermo Abesada-Terk Jr. has 1 award and honors on record

Dmand AI lists 1 award for Dr. Abesada-Terk, most recently CMS Stage 1 EHR in 2012.

Awards and honors for Dr. Abesada-Terk

  1. 2012
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. Guillermo Abesada-Terk Jr. graduated from University of Miami, Miller School of Medicine

Dr. Abesada-Terk graduated from University of Miami, Miller School of Medicine in 1985.

  1. Medical schoolUniversity of Miami, Miller School of Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Guillermo Abesada-Terk Jr. accepts plans from 3 insurance carriers

Dr. Abesada-Terk is in network with 3 carriers, including Excellus BlueCross BlueShield, Cigna and Molina. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.

  • Excellus BlueCross BlueShield
  • Cigna
  • Molina

Plan types Dr. Abesada-Terk accepts, by number of carriers

  1. HMO3
  2. Medicare3
  3. PPO2
  4. EPO1
  5. POS1

Source: Dmand AI Insurance Network Data

Sources for Dr. Guillermo Abesada-Terk Jr.'s profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Guillermo Abesada-Terk Jr.

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Guillermo Abesada-Terk Jr.'s NPI number?

Dr. Guillermo Abesada-Terk Jr.'s NPI number is 1134313273. It was assigned on August 31, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Guillermo Abesada-Terk Jr.?

Dr. Guillermo Abesada-Terk Jr. is a medical oncologist in Spring Hill, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Guillermo Abesada-Terk Jr. practice?

Dr. Abesada-Terk practices at 501 Se Osceola St, Stuart, FL 34994-2301. Dr. Abesada-Terk also practices at 11063 County Line Rd, Spring Hill, FL 34609. Dr. Abesada-Terk's primary practice is Coastal Oncology and Hematology in Stuart, Florida.

What is Dr. Guillermo Abesada-Terk Jr.'s office phone number?

The practice phone on file for Dr. Abesada-Terk is (772) 223-5952.

What is Dr. Guillermo Abesada-Terk Jr.'s medical license number?

Dr. Abesada-Terk holds Florida license ME58862, one of the licenses on file in 2 states.

Which states has Dr. Guillermo Abesada-Terk Jr. been licensed in?

Dmand AI has state licenses on file for Dr. Abesada-Terk in Florida (1990 to 2027) and Pennsylvania (1988 to 1992).

Does Dr. Guillermo Abesada-Terk Jr. accept Medicare?

Yes. CMS data shows Dr. Abesada-Terk billed Medicare for 51,789 services in 2022.

Is Dr. Guillermo Abesada-Terk Jr. board certified?

Yes. Dr. Abesada-Terk is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Guillermo Abesada-Terk Jr. bill to Medicare?

In 2022, Dr. Abesada-Terk's most billed Medicare services were medicare temporary code (Q0138), injected or infused drug (J2182) and medicare temporary code (Q5106).

Where did Dr. Guillermo Abesada-Terk Jr. go to medical school?

Dr. Abesada-Terk graduated from University of Miami, Miller School of Medicine in 1985.

Show 6 more questionsShow fewer questions

What drugs does Dr. Guillermo Abesada-Terk Jr. prescribe most?

In 2022 Medicare Part D data, Dr. Abesada-Terk's most prescribed drugs by claims were Letrozole, Revlimid and Hydroxyurea.

Has Dr. Guillermo Abesada-Terk Jr. received payments from drug or device companies?

CMS Open Payments shows $20,040 in general payments to Dr. Abesada-Terk from 67 companies from 2016 to 2024. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. Guillermo Abesada-Terk Jr. been practicing?

Dr. Abesada-Terk graduated from medical school in 1985, 41 years ago.

Does Dr. Guillermo Abesada-Terk Jr. do research?

Dmand AI links 7 publications to Dr. Abesada-Terk, published from 2010 to 2014. Dr. Abesada-Terk has worked on 7 clinical trials.

Who does Dr. Guillermo Abesada-Terk Jr. publish with?

Dr. Abesada-Terk's most frequent co-authors are Carlos A. Alemany, MD (7 shared papers), Thomas Howard Cartwright, MD (6 shared papers) and Douglas E. Faig, MD (6 shared papers).

What insurance does Dr. Guillermo Abesada-Terk Jr. accept?

Dr. Abesada-Terk is in network with 3 carriers, including Excellus BlueCross BlueShield, Cigna and Molina. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)